Skip to main content

Advertisement

Articles

Page 1 of 11

  1. To evaluate clinical outcomes after either immediate or deferred initiation of antiretroviral therapy in HIV-1-infected patients, presenting late with pneumocystis pneumonia (PCP) or toxoplasma encephalitis (TE).

    Authors: Guido Schäfer, Christian Hoffmann, Keikawus Arasteh, Dirk Schürmann, Christoph Stephan, Björn Jensen, Matthias Stoll, Johannes R. Bogner, Gerd Faetkenheuer, Jürgen Rockstroh, Hartwig Klinker, Georg Härter, Albrecht Stöhr, Olaf Degen, Eric Freiwald, Anja Hüfner…

    Citation: AIDS Research and Therapy 2019 16:34

    Content type: Research

    Published on:

  2. We previously reported that four doses or four double doses of hepatitis B vaccination regimens could not significantly increase a response rate compared with standard doses. However, the antibody levels were ...

    Authors: Romanee Chaiwarith, Jutarat Praparattanapan, Wilai Kotarathititum, Jiraprapa Wipasa, Kanokporn Chaiklang and Khuanchai Supparatpinyo

    Citation: AIDS Research and Therapy 2019 16:33

    Content type: Short Report

    Published on:

  3. Suboptimal adherence to HIV antiretroviral therapy (ART) and concomitant lack of viral control can have severe consequences for health and onward transmission among persons living with HIV. Little is known abo...

    Authors: James M. McMahon, Amy Braksmajer, Chen Zhang, Natalie Leblanc, Michael Chen, Angela Aidala and Janie Simmons

    Citation: AIDS Research and Therapy 2019 16:32

    Content type: Research

    Published on:

  5. Expanded access to antiretroviral therapy (ART) leads to improved HIV/AIDS treatment outcomes in Nigeria, however, increasing rates of loss to follow-up among those on ART is threatening optimal standard achie...

    Authors: Ahmad Aliyu, Babatunde Adelekan, Nifarta Andrew, Eunice Ekong, Stephen Dapiap, Fati Murtala-Ibrahim, Iboro Nta, Nicaise Ndembi, Charles Mensah and Patrick Dakum

    Citation: AIDS Research and Therapy 2019 16:30

    Content type: Research

    Published on:

  6. As antiretroviral therapy (ART) programs expand access, there is an increase in burden to a healthcare system. These results are reduced provider-patient contact time and poor programmatic and patient outcomes...

    Authors: Ahmad Aliyu, Samer El-Kamary, Jessica Brown, Bruce Agins, Nicaise Ndembi, Gambo Aliyu, Jibreel Jumare, Babatunde Adelekan, Patrick Dakum, Alash’le Abimiku and Manhattan Charurat

    Citation: AIDS Research and Therapy 2019 16:29

    Content type: Review

    Published on:

  7. Limited data are available regarding correlates of regular sexually transmitted infections (STIs) and HIV screening among female sex workers (FSW) in Sub-Saharan Africa. In this study, we aimed to assess the f...

    Authors: Richard Muhindo, Barbara Castelnuovo, Andrew Mujugira, Rosalind Parkes-Ratanshi, Nelson K. Sewankambo, Juliet Kiguli, Nazarius Mbona Tumwesigye and Edith Nakku-Joloba

    Citation: AIDS Research and Therapy 2019 16:28

    Content type: Research

    Published on:

  8. A negative status following confirmatory Early Infant Diagnosis (EID) is the desired pediatric outcome of prevention of Mother to Child Transmission (PMTCT) programs. EID impacts epidemic control by confirming...

    Authors: Patrick Dakum, Monday Tola, Nta Iboro, Chukwuemeka A. Okolo, Olachi Anuforom, Christopher Chime, Sam Peters, Jibreel Jumare, Obinna Ogbanufe, Aliyu Ahmad and Nicaise Ndembi

    Citation: AIDS Research and Therapy 2019 16:27

    Content type: Research

    Published on:

  9. According to the user instructions from the manufacturer of OraQuick HIV self-test (HIVST) kits, individuals whose kits show one red band should be considered to be HIV-negative, no matter how weak the band is...

    Authors: Rose Kisa, Joseph K. B. Matovu, Esther Buregyeya, William Musoke, Caroline J. Vrana-Diaz, Jeffrey E. Korte and Rhoda K. Wanyenze

    Citation: AIDS Research and Therapy 2019 16:26

    Content type: Short Report

    Published on:

  10. Thailand has the highest prevalence of HIV among countries in Asia but has also been a pioneer in HIV prevention and treatment efforts in the region, reducing the incidence of new infections significantly over...

    Authors: Camilla Muccini, Trevor A. Crowell, Eugène Kroon, Carlo Sacdalan, Reshmie Ramautarsing, Pich Seekaew, Praphan Phanuphak, Jintanat Ananworanich, Donn J. Colby and Nittaya Phanuphak

    Citation: AIDS Research and Therapy 2019 16:25

    Content type: Review

    Published on:

  11. Two HIV virus types exist: HIV-1 is pandemic and aggressive, whereas HIV-2 is confined mainly to West Africa and less pathogenic. Despite the fact that it has been almost 40 years since the discovery of AIDS, ...

    Authors: Joakim Esbjörnsson, Marianne Jansson, Sanne Jespersen, Fredrik Månsson, Bo L. Hønge, Jacob Lindman, Candida Medina, Zacarias J. da Silva, Hans Norrgren, Patrik Medstrand, Sarah L. Rowland-Jones and Christian Wejse

    Citation: AIDS Research and Therapy 2019 16:24

    Content type: Review

    Published on:

  12. Darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) 800/150/200/10 mg is a once-daily, single-tablet regimen for treatment of HIV-1 infection. The efficacy/safety of switching to D/C/F/TAF ver...

    Authors: Gregory D. Huhn, Joseph J. Eron, Pierre-Marie Girard, Chloe Orkin, Jean-Michel Molina, Edwin DeJesus, Romana Petrovic, Donghan Luo, Erika Van Landuyt, Erkki Lathouwers, Richard E. Nettles, Kimberley Brown and Eric Y. Wong

    Citation: AIDS Research and Therapy 2019 16:23

    Content type: Research

    Published on:

  13. There are approximately 72,000 people living with HIV/AIDS (PLHIV) in Peru. Non-adherence to antiretroviral therapy (ART) is the most important factor for therapeutic failure and the development of resistance....

    Authors: Juan M. Leyva-Moral, Blanca K. Loayza-Enriquez, Patrick A. Palmieri, Genesis M. Guevara-Vasquez, Ursula E. Elias-Bravo, Joan E. Edwards, María Feijoo-Cid, Lucy Y. Davila-Olano, Juan R. Rodriguez-Llanos and Franco E. Leon-Jimenez

    Citation: AIDS Research and Therapy 2019 16:22

    Content type: Research

    Published on:

  14. Study aim was to evaluate the safety and durability of darunavir/cobicistat (DRV/c) in a real life setting.

    Authors: Lucia Taramasso, Elena Ricci, Antonio Cascio, Laura Valsecchi, Barbara Menzaghi, Nicola Squillace, Paolo Maggi, Giuseppe Vittorio De Socio, Chiara Dentone, Giordano Madeddu, Giovanni F. Pellicanò, Leonardo Calza, Goffredo Angioni, Paolo Bonfanti and Antonio Di Biagio

    Citation: AIDS Research and Therapy 2019 16:21

    Content type: Research

    Published on:

  15. The South African public health system plays an important role in the delivery of HIV testing and treatment services. The health system is also an important conduit for targeted behaviour change communication ...

    Authors: Gavin George, Sean Beckett, Cherie Cawood, David Khanyile, Kaymarlin Govender and Ayesha B. M. Kharsany

    Citation: AIDS Research and Therapy 2019 16:20

    Content type: Research

    Published on:

  16. Brazil is a low-and-middle income country (LMIC) that, despite having a large population and continental dimensions, has been able to successfully fight HIV/AIDS through a number of governmental and societal m...

    Authors: Adele S. Benzaken, Gerson F. M. Pereira, Lendel Costa, Amilcar Tanuri, André F. Santos and Marcelo A. Soares

    Citation: AIDS Research and Therapy 2019 16:19

    Content type: Review

    Published on:

  18. People living with HIV (PLHIV) constantly need to address social issues such as the cost of accessing care, stigma, and lack of social support which impacts on their level of adherence to clinic visits or anti...

    Authors: Babatunde Adelekan, Nifarta Andrew, Iboro Nta, Asabe Gomwalk, Nicaise Ndembi, Charles Mensah, Patrick Dakum and Ahmad Aliyu

    Citation: AIDS Research and Therapy 2019 16:17

    Content type: Research

    Published on:

  20. Human herpes virus 8 (HHV8) is the causative agent of Kaposi’s sarcoma and has been associated with an increasing number of hematologic diseases such as primary effusion lymphoma (PEL) (both classic and extrac...

    Authors: Laura Campogiani, Carlotta Cerva, Gaetano Maffongelli, Elisabetta Teti, Livio Pupo, Sara Vaccarini, Maria Cantonetti, Alfredo Pennica, Massimo Andreoni and Loredana Sarmati

    Citation: AIDS Research and Therapy 2019 16:15

    Content type: Case Report

    Published on:

  21. Infection with the human immunodeficiency virus (HIV) is an alarming problem in North African countries, but few studies have analyzed the geographical distribution of the epidemic. Libya, the second largest c...

    Authors: Mohamed A. Daw, Amina M. Daw, Nadia E. M. Sifennasr, Aisha M. Draha, Ahmed A. Daw, Ali A. Daw, Mohamed O. Ahmed, Ebtisam S. Mokhtar, Abdallah Hu. El-Bouzedi, Ibrahem M. Daw, Samia I. Adam and Saed Warrag

    Citation: AIDS Research and Therapy 2019 16:14

    Content type: Research

    Published on:

  22. Men who have sex with men (MSM) are amongst populations at-risk for HIV acquisition in Thailand. In youth MSM (aged 15–24 years), the incidence of HIV infection has substantially increased. However, data on HI...

    Authors: Thana Khawcharoenporn, Suteera Mongkolkaewsub, Chanon Naijitra, Worawoot Khonphiern, Anucha Apisarnthanarak and Nittaya Phanuphak

    Citation: AIDS Research and Therapy 2019 16:13

    Content type: Research

    Published on:

  23. Data on chronic kidney disease development in HIV infection is important towards building a comprehensive knowledge of HIV, ageing and polypharmacy in Africa. Several previous studies on tenofovir-associated k...

    Authors: Takudzwa J. Mtisi, Chiratidzo E. Ndhlovu, Chiedza C. Maponga and Gene D. Morse

    Citation: AIDS Research and Therapy 2019 16:12

    Content type: Review

    Published on:

  24. As in non-infected subjects, statins and aspirin have a pivotal preventive role in reducing the cardiovascular related morbidity and mortality in HIV infected patients. The persistence of immune activation in ...

    Authors: P. Maggi, G. V. De Socio, S. Cicalini, M. D’Abbraccio, G. Dettorre, A. Di Biagio, C. Martinelli, G. Nunnari, S. Rusconi, L. Sighinolfi, V. Spagnuolo and N. Squillace

    Citation: AIDS Research and Therapy 2019 16:11

    Content type: Methodology

    Published on:

  25. Presence of isolated anti-HBc antibody is common in HIV-infected patients in endemic areas and could be caused by prior HBV infection with loss of anti-HBs antibody. The role of vaccination in these patients r...

    Authors: Nattinee Laksananun, Jutarat Praparattanapan, Wilai Kotarathititum, Khuanchai Supparatpinyo and Romanee Chaiwarith

    Citation: AIDS Research and Therapy 2019 16:10

    Content type: Research

    Published on:

  26. Practical screening strategies are necessary to detect neurocognitive impairment of all severities in HIV populations, which remains prevalent despite highly active antiretroviral therapy and requires full neu...

    Authors: Lai Gwen Chan, Mei Jing Ho, Yijun Carol Lin, Yining Ong and Chen Seong Wong

    Citation: AIDS Research and Therapy 2019 16:9

    Content type: Research

    Published on:

  27. The World Health Organization and Tanzanian National Guidelines for HIV and AIDS management, recommends provider initiated testing and counseling for HIV at any point of health care contact. In Tanzania, over ...

    Authors: Juma Ramadhani, Hendry R. Sawe, Said S. Kilindimo, Juma A. Mfinanga and Ellen J. Weber

    Citation: AIDS Research and Therapy 2019 16:8

    Content type: Research

    Published on:

  28. Long-term success of cART is possible if the regimen is convenient and less-toxic. This study assessed the efficacy and safety of switching from a first-line NNRTI or boosted PI-based regimens to RPV-based reg...

    Authors: Sivaporn Gatechompol, Anchalee Avihingsanon, Tanakorn Apornpong, Win Min Han, Stephen J. Kerr and Kiat Ruxrungtham

    Citation: AIDS Research and Therapy 2019 16:7

    Content type: Research

    Published on:

  29. This study aimed to investigate the prevalence of HIV late presentation and advanced HIV disease and to identify the factors associated with HIV late presentation and advanced HIV disease among patients with n...

    Authors: Xi Hu, Bingyu Liang, Chongxing Zhou, Junjun Jiang, Jiegang Huang, Chuanyi Ning, Jie Liu, Bo Zhou, Ning Zang, Jinzhen Lai, Rongfeng Chen, Yanyan Liao, Peijiang Pan, Xin Liu, Guanghua Lan, Xianwu Pang…

    Citation: AIDS Research and Therapy 2019 16:6

    Content type: Research

    Published on:

  30. High rates of non-nucleoside reverse transcriptase inhibitors (NNRTI) resistance was a key consideration in the WHO policies transitioning first-line regimens to include integrase inhibitors (dolutegravir [DTG...

    Authors: Sarah E. Rutstein, Jane S. Chen, Julie A. E. Nelson, Samuel Phiri, William C. Miller and Mina C. Hosseinipour

    Citation: AIDS Research and Therapy 2019 16:5

    Content type: Short Report

    Published on:

  31. Despite the advances in therapy, the occurrence of drug-resistant human immunodeficiency virus type 1 (HIV-1) is a major obstacle to successful treatment. This study aimed to characterize the genetic diversity...

    Authors: Larissa Danielle Bahls, Pedro Henrique Canezin, Edna Maria Vissoci Reiche, José Carlos Couto Fernandez, José Ricardo Colleti Dias, Vera Alice Fernandes Meneguetti, Luis Toshio Ueda and Dennis Armando Bertolini

    Citation: AIDS Research and Therapy 2019 16:4

    Content type: Research

    Published on:

  32. Our understanding of HIV-1 and antiretroviral treatment (ART) is strongly biased towards subtype B, the predominant subtype in North America and western Europe. Efforts to characterize the response to first-li...

    Authors: Art F. Y. Poon, Emmanuel Ndashimye, Mariano Avino, Richard Gibson, Cissy Kityo, Fred Kyeyune, Immaculate Nankya, Miguel E. Quiñones-Mateu and Eric J. ARTS

    Citation: AIDS Research and Therapy 2019 16:3

    Content type: Research

    Published on:

  33. Antiretroviral therapy (ART) use by people living with HIV reduces HIV transmission, morbidity, mortality, and improves quality of life. Good ART adherence is required to achieve these benefits. We investigate...

    Authors: Dominic Bukenya, Billy Nsubuga Mayanja, Sarah Nakamanya, Richard Muhumuza and Janet Seeley

    Citation: AIDS Research and Therapy 2019 16:2

    Content type: Research

    Published on:

  34. HLA-B*57:01 screening was added to clinical care guidelines in 2008 to reduce the risk of hypersensitivity reaction from abacavir. The uptake of HLA-B*57:01 screening and incidence of hypersensitivity reaction...

    Authors: Karam Mounzer, Ricky Hsu, Jennifer S. Fusco, Laurence Brunet, Cassidy E. Henegar, Vani Vannappagari, Chris M. Stainsby, Mark S. Shaefer, Leigh Ragone and Gregory P. Fusco

    Citation: AIDS Research and Therapy 2019 16:1

    Content type: Research

    Published on:

  36. The management of visceral leishmaniasis (VL) in HIV-infected patients is often complex with patients experiencing higher mortality rates, more toxic side effects and a higher possibility of treatment failure ...

    Authors: Antonio Mastroianni, Paolo Gaibani, Giada Rossini, Caterina Vocale, Maria Carla Re, Gianfranco Ravaglia, Vittorio Sambri and Stefania Varani

    Citation: AIDS Research and Therapy 2018 15:27

    Content type: Case Report

    Published on:

  39. Voluntary medical male circumcision (VMMC) is a critical component of HIV prevention. VMMC policies have achieved initial targets in adult men yet continue to fall short in reaching younger men and adolescents.

    Authors: O. Galárraga, P. Shah, M. Wilson-Barthes, D. Ayuku and P. Braitstein

    Citation: AIDS Research and Therapy 2018 15:24

    Content type: Short Report

    Published on:

  40. Studies relating to long-term virological outcomes among children on first-line antiretroviral therapy (ART) from low and middle-income countries are limited.

    Authors: Padmapriyadarsini Chandrasekaran, Anita Shet, Ramalingam Srinivasan, G. N. Sanjeeva, Sudha Subramanyan, Suba Sunderesan, Karunaianantham Ramesh, Bindu Gopalan, Elumalai Suresh, Navaneethan Poornagangadevi, Luke E. Hanna, Chockalingam Chandrasekar, Christine Wanke and Soumya Swaminathan

    Citation: AIDS Research and Therapy 2018 15:23

    Content type: Research

    Published on:

  42. Like other countries, Tanzania instituted mobile and outreach testing approaches to address low HIV testing rates at health facilities and enhance linkage to care. Available evidence from hard-to-reach rural s...

    Authors: Erica S. Sanga, Ferdinand C. Mukumbang, Adiel K. Mushi, Willyhelmina Olomi, Wondwossen Lerebo and Christina Zarowsky

    Citation: AIDS Research and Therapy 2018 15:21

    Content type: Research

    Published on:

  43. Adolescents living with HIV on antiretroviral therapy (ART) have worse treatment adherence, viral suppression, and mortality rates compared to adults. This study investigated factors associated with viral non-...

    Authors: Kolab Chhim, Gitau Mburu, Sovannary Tuot, Ratana Sopha, Vohith Khol, Pheak Chhoun and Siyan Yi

    Citation: AIDS Research and Therapy 2018 15:20

    Content type: Research

    Published on:

  44. The life expectancy of people living with HIV (PLHIV) has dramatically improved with effective and well-tolerated antiretroviral therapy. This presents a new challenge in caring for this patient population, wi...

    Authors: Mark Bloch

    Citation: AIDS Research and Therapy 2018 15:19

    Content type: Review

    Published on:

  45. The widespread global access to antiretroviral drugs has led to considerable reductions in morbidity and mortality but, unfortunately, the risk of virologic failure increases with the emergence, and potential ...

    Authors: Nicholas Silver, Mary Paynter, Georgina McAllister, Maureen Atchley, Christine Sayir, John Short, Dane Winner, David J. Alouani, Freddie H. Sharkey, Kicki Bergefall, Kate Templeton, David Carrington and Miguel E. Quiñones-Mateu

    Citation: AIDS Research and Therapy 2018 15:18

    Content type: Research

    Published on:

  46. To compare outcomes with single tablet regimens (STR) versus multi-tablet regimens (MTR) for human immunodeficiency virus (HIV) treatment using published data.

    Authors: Patrick G. Clay, Wei C. Yuet, Christiane H. Moecklinghoff, Inge Duchesne, Krzysztof L. Tronczyński, Sandip Shah and Dong Shao

    Citation: AIDS Research and Therapy 2018 15:17

    Content type: Research

    Published on:

  47. Non-AIDS defining cancers (NADCs) have been an increasing cause of morbidity and mortality in patients with HIV. There is no data on the spectrum of NADCs in Mexico. We describe the type of neoplasms, clinical...

    Authors: P. Cornejo-Juárez, D. Cavildo-Jerónimo and P. Volkow-Fernández

    Citation: AIDS Research and Therapy 2018 15:16

    Content type: Research

    Published on:

  48. While the effects of initiation of antiretroviral treatment (ART) on risky sexual behavior have been extensively studied, less is known about the long-term changes in risky sexual behavior over time in resourc...

    Authors: Stephen Okoboi, Barbara Castelnuovo, David M. Moore, Joseph Musaazi, Andrew Kambugu, Josephine Birungi, Pontiano Kaleebu, Mastula Nanfuka, Moses R. Kamya and Annelies Van Rie

    Citation: AIDS Research and Therapy 2018 15:15

    Content type: Research

    Published on:

  49. It has been speculated that the prevalence of chemsex is increasing in men who have sex with men and that this may be playing a role in the spread of HIV.

    Authors: Chris Kenyon, Kristien Wouters, Tom Platteau, Jozefien Buyze and Eric Florence

    Citation: AIDS Research and Therapy 2018 15:14

    Content type: Research

    Published on:

  50. Immune restoration is often incomplete after ART in HIV patients, both quantitatively and qualitatively. We studied the incidence and probability of CD4/CD8 normalization in an adult Thai HIV cohort and explor...

    Authors: Win Min Han, Tanakorn Apornpong, Stephen J. Kerr, Akarin Hiransuthikul, Sivaporn Gatechompol, Tanya Do, Kiat Ruxrungtham and Anchalee Avihingsanon

    Citation: AIDS Research and Therapy 2018 15:13

    Content type: Research

    Published on:

  • ISSN: 1742-6405 (electronic)

Advertisement

AIDS Research and Therapy

ISSN: 1742-6405

Contact us